NO139590B - DENTAL CARE FOR AA PREVENT THE FORMATION OF DENTAL COATINGS - Google Patents

DENTAL CARE FOR AA PREVENT THE FORMATION OF DENTAL COATINGS Download PDF

Info

Publication number
NO139590B
NO139590B NO4721/72A NO472172A NO139590B NO 139590 B NO139590 B NO 139590B NO 4721/72 A NO4721/72 A NO 4721/72A NO 472172 A NO472172 A NO 472172A NO 139590 B NO139590 B NO 139590B
Authority
NO
Norway
Prior art keywords
dental
bonds
formation
cariogenanase
cariogenan
Prior art date
Application number
NO4721/72A
Other languages
Norwegian (no)
Other versions
NO139590C (en
Inventor
Thomas Henry Stoudt
Karl Heinz Nollstadt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO139590B publication Critical patent/NO139590B/en
Publication of NO139590C publication Critical patent/NO139590C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/366Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/368Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01059Glucan endo-1,3-alpha-glucosidase (3.2.1.59)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01071Glucan endo-1,2-beta-glucosidase (3.2.1.71)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01084Glucan 1,3-alpha-glucosidase (3.2.1.84), i.e. mutanase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dental Preparations (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Tannpleiemiddel for å hindre dannelse av tannbelegg.Tooth care agent to prevent the formation of dental plaque.

Description

Foreliggende oppfinnelse angår tannpleiemidler inneholdende enzymer som aktiv bestanddel, for å hindre dannelse av tannbelegg. The present invention relates to dental care products containing enzymes as an active ingredient, to prevent the formation of dental plaque.

Det er vel kjent at menneskelig tannbelegg spiller en viktig rolle ved utvikling av caries, tannsten og tannsykdommer, som er vesentlige sunnhetsproblemer som bør forhindres ved riktig oral . hygiene. It is well known that human dental plaque plays an important role in the development of caries, tartar and dental diseases, which are significant health problems that should be prevented by proper oral hygiene. hygiene.

Tannbelegg kleber til tennene og tannkjøttvev og opprett-holdes, i det minste delvis, av polysaccharider og proteiner. Et av disse polysaccharider, et glucan, er tidligere erkjent som dextran som er utsatt for enzymatisk hydrolyse av dextranaser. Inkorporeringen av dextranaser i orale hygieneprodukter har vært foreslått i U.S. patent nr. 3 686 393. På lignende måte har anvendelsen av tannbelegg-dispergerende proteaser for oral hygiene vært foreslått av Mollé i J. So. Calif. Dent. Assn., 35, 391 Dental plaque adheres to the teeth and gum tissue and is held up, at least in part, by polysaccharides and proteins. One of these polysaccharides, a glucan, has previously been recognized as dextran which is subject to enzymatic hydrolysis by dextranases. The incorporation of dextranases into oral hygiene products has been proposed in U.S. Pat. patent no. 3,686,393. In a similar way, the use of plaque-dispersing proteases for oral hygiene has been proposed by Mollé in J. So. Calif. Dent. Assn., 35, 391

(1967) og av Shaver et al. i J. Periodontology, 41, 33 (1970). (1967) and by Shaver et al. in J. Periodontology, 41, 33 (1970).

Det har vist seg at tannbelegg inneholder et annet spesielt glucan i mengder omtrent like med dextran, og som motstår den hydrolytiske virkning av dextranase, og som har fått navnet "cariogenan", som er et rettkjedet glucan med a-(1 —>3)-bindinger og a-(1—*2)-bindinger i forholdet ca. 1:3. It has been found that dental plaque contains another special glucan in amounts approximately equal to dextran, and which resists the hydrolytic action of dextranase, and which has been named "cariogenan", which is a straight-chain glucan with a-(1 —>3) -bonds and a-(1—*2)-bonds in the ratio approx. 1:3.

Det har nu vist seg at tidligere ukjente enzymer er i stane til enzymatisk å nedbryte cariogenan-bestanddelen av tannbelegg. Disse enzymer er blitt betegnet som "cariogenanaser", og deres systematiske navn er a-^^-glucanohydrolase. It has now been shown that previously unknown enzymes are capable of enzymatically breaking down the cariogenan component of dental plaque. These enzymes have been termed "cariogenanases" and their systematic name is α-^^-glucanohydrolase.

På grunn av cariogenanasenes evne til å nedbryte cariogenan, som er et av klebemidlene i tannbelegg, finner de anvendelse som en bestanddel i tannpleiemidler som tannpastaer og munnvann, Due to the cariogenases' ability to break down cariogenan, which is one of the adhesives in dental plaque, they find use as an ingredient in dental care products such as toothpastes and mouthwashes,

eller i tyggegummi eller i høyhastighets-stråler av vann, som et nyttig hjelpemiddel sammen med dextranase. or in chewing gum or in high-velocity jets of water, as a useful adjunct with dextranase.

Foreliggende oppfinnelse angår et tannpleiemiddel for å hindre dannelse av tannbelegg, hvilket middel inneholder dextranase og eventuelt protease, og kjsnnetegnes ved at det dessuten inneholder cariogenanase, som enzymatisk spalter i tannbelegg tilstedeværende cariogenan (dvs. rettkjedet glucan med a-(l->3)-bindinger og a-(l—>2)-bindinger i forholdet ca. 3 = 1) > i er» mengde på 5 - 20.000 enheter pr. 1 g eller 1 ml middel, hvilken cariogenanases systematiske navn er a~ -glucan-3-glucanohydrolase og som er et endo-enzym som innvirker på andre enn endebindingene av polysaccharidkjeden, slik at spaltningsproduktene er hovedsakelig di-, tri- og andre oligosaccharider, og som kjennetegnes ved a) spesifisitet til en slik a-(l—>3)-glucosidbinding, i hvis nærhet der finnes en a-(1—>2)-glucosidbinding, The present invention relates to a dental care agent to prevent the formation of dental plaque, which agent contains dextranase and possibly protease, and is characterized by the fact that it also contains cariogenanase, which enzymatically cleaves cariogenan present in dental plaque (i.e. straight-chain glucan with a-(l->3) -bonds and a-(l—>2)-bonds in the ratio approx. 3 = 1) > i is» amount of 5 - 20,000 units per 1 g or 1 ml agent, the systematic name of cariogenanase is a~-glucan-3-glucanohydrolase and which is an endo-enzyme that acts on other than the end bonds of the polysaccharide chain, so that the cleavage products are mainly di-, tri- and other oligosaccharides, and which is characterized by a) specificity of such an α-(l—>3)-glucosidic bond, in the vicinity of which there is an α-(1—>2)-glucosidic bond,

b) et isoelektrisk punkt på 5,1, og b) an isoelectric point of 5.1, and

c) en optimalaktivitet, som dekker et vidt' pH-område, med c) an optimal activity, which covers a wide pH range, with

toppaktivitet ved 6,0. peak activity at 6.0.

Tannpleiemidlet bør være sammensatt slik at en enkelt be-handling vil utsette munnen for 10 - 20.000 enheter av cariogenanase og lOO - 200.000 enheter dextranase, og én eller flere an-vendelser pr. dag er ønskelig. The dental care agent should be composed so that a single treatment will expose the mouth to 10 - 20,000 units of cariogenanase and lOO - 200,000 units of dextranase, and one or more applications per day is desirable.

Menneskelig tannbelegg ble isolert fra en rekke forsøks-personer ved fysikalsk skrapning av tennene og viste seg å inne-holde på tørrvektsbasis fra 0,6 til 2,5% av dextranasebestandig polysaccharid. Human dental plaque was isolated from a number of subjects by physical scraping of the teeth and was found to contain on a dry weight basis from 0.6 to 2.5% of dextranase-resistant polysaccharide.

Det samme polysaccharid, sammen med dextran, ble vist å dannes, in vitro, av Streptococcus mutans SL-1 (NRRL nr. B-5304) The same polysaccharide, together with dextran, was shown to be formed, in vitro, by Streptococcus mutans SL-1 (NRRL No. B-5304)

ved dyrkning i et medium inneholdende sucrose som carbohydratkilde, og også når en cellefri Streptococcus mut ans-buljong inneholdende ekstracellulære enzymer ble inkubert med en sucrose-oppløsning. when cultured in a medium containing sucrose as a carbohydrate source, and also when a cell-free Streptococcus mutans broth containing extracellular enzymes was incubated with a sucrose solution.

I hvert tilfelle ble cariogenan skilt fra det ledsagende dextran ved inkubering med dextranase.. Cariogenanet ble renset ytterligere ved deproteinisering ved standardmetoder. In each case, the cariogenan was separated from the accompanying dextran by incubation with dextranase. The cariogenan was further purified by deproteinization by standard methods.

Strukturen av cariogenan ble bestemt ved standardmetoder som innbefatter delvis syrehydrolyse fulgt av kvalitativ og kvantita-tiv analyse av de oligosaccharide fraksjoner erholdt derved, og ved metaperjodatoxydasjons- og borhydridreduksjonsstudier. Strukturen ble således bestemt til å være et uforgrenet glucan med a-(l—>3)- og a-(l->2)-bindinger i et forhold på ca. 3:1. The structure of cariogenan was determined by standard methods which include partial acid hydrolysis followed by qualitative and quantitative analysis of the oligosaccharide fractions obtained thereby, and by metaperiodate oxidation and borohydride reduction studies. The structure was thus determined to be an unbranched glucan with α-(l->3) and α-(l->2) bonds in a ratio of approx. 3:1.

Mikrobielle organismer som er i stand til enzymatisk å hydrolysere cariogenan, isoleres fra luftbårne bakterier ved å utsette agarplater inneholdende et passende næringsmedium innbe-fattende cariogenan som en carbohydratkilde og inkubere de erholdte kulturer ved en passende temperatur, vanligvis 28 - 37°C Microbial organisms capable of enzymatically hydrolyzing cariogenan are isolated from airborne bacteria by exposing agar plates containing a suitable nutrient medium containing cariogenan as a carbohydrate source and incubating the cultures obtained at a suitable temperature, usually 28-37°C

i inntil ca. IO dager. Organismer funnet å være aktive dyrkes videre på lignende agarplater for å isolere dem. for up to approx. 10 days. Organisms found to be active are further cultured on similar agar plates to isolate them.

Det ekstracellulære enzym, cariogenanase, fremstilles i isolerbare mengder ved å inkubere en kultur av en cariogenanase-oppbyggende mikroorganisme ved en passende temperatur, vanligvis 28 - 37°C, i et næringsmedium i rystekolber inntil en passende grad av cariogenanase-aktivitet er oppnådd, vanligvis fra 72 til 96 timer. I alminnelighet krever ikke mikroorganismene cariogenan som en carbohydratkilde i næringsmediet for oppbygning av cariogenanase. En av organismene, Bacillus sp. MB-2665 (NRRL nr. B-5300), anvendt for å eksemplifisere oppfinnelsen, krevet im-idlex tid cariogenan som et næringsstoff. Ved konvensjonelle muterings-metoder kan imidlertid en konstitutiv mutant frembringes som ikke krever cariogenan i mediet. The extracellular enzyme, cariogenanase, is produced in isolable amounts by incubating a culture of a cariogenanase-producing microorganism at a suitable temperature, usually 28 - 37°C, in a nutrient medium in shake flasks until a suitable degree of cariogenanase activity is obtained, usually from 72 to 96 hours. In general, the microorganisms do not require cariogenan as a carbohydrate source in the nutrient medium for building up cariogenanase. One of the organisms, Bacillus sp. MB-2665 (NRRL No. B-5300), used to exemplify the invention, required im-idlex tid cariogenan as a nutrient. By conventional mutation methods, however, a constitutive mutant can be produced which does not require cariogenan in the medium.

Enzymet isoleres fra dyrkningsmediet ved å klare det for celleavfall og andre uoppløselige stoffer ved sentrifugering eller filtrering, konsentrere sentrifugatet 5-15 ganger, fortrinnsvis ca. IO ganger i vakuum, og felle proteinet ved standardmetoder som med et organisk oppløsningsmiddel, ved kompieksdannelse med metall, eller ved metning med et salt som ammoniumsulfat eller lignende. Det foretrekkes å anvende flere feininger med mellom-liggende oppløsninger av'bunnfallet i en pufferoppløsning og klar ing av de erholdte oppløsninger ved filtrering eller sent rif uger in.. Sluttbunnfallet i vandig oppløsning dialyseres så og oppbevares enten som en kold oppløsning eller i lyofilisert form. The enzyme is isolated from the culture medium by clearing it of cell waste and other insoluble substances by centrifugation or filtration, concentrating the centrifugate 5-15 times, preferably approx. 10 times in vacuum, and precipitate the protein by standard methods such as with an organic solvent, by complexation with metal, or by saturation with a salt such as ammonium sulfate or the like. It is preferable to use several filtrations with intermediate solutions of the precipitate in a buffer solution and clarification of the obtained solutions by filtration or late rif weeks in. The final precipitate in aqueous solution is then dialyzed and stored either as a cold solution or in lyophilized form .

Det således dannede enzym var karakterisert ved at det var spesifikt for en a-( l-»3) -glucosidbinding med en nabo a-(l—>2)-glucosidbinding. Det har et isoelektrisk fokuseringspunkt på 5,1. Det har et bredt pH-optimum med toppaktivitet ved pH 6,0. Disse egenskaper skiller cariogenanase klart fra enhver kjent type av polysaccharase. The enzyme thus formed was characterized in that it was specific for an α-(l-»3)-glucosidic bond with a neighboring α-(l->2)-glucosidic bond. It has an isoelectric focusing point of 5.1. It has a wide pH optimum with peak activity at pH 6.0. These properties clearly distinguish cariogenanase from any known type of polysaccharase.

En fremgangsmåte ved fremstilling av enzymet cariogenanase er beskrevet og beskyttet i norsk patent nr. 138'4H-Sammenligningsforsøk A method for producing the enzyme cariogenanase is described and protected in Norwegian patent no. 138'4H-Sammenligningsforsøk

In vitro belegg på bunnen og veggene av 5 små tarerte dyrkningskolber ble dannet ved dyrkning av Streptococcus mutans. Disse belegg ble behandlet hver for seg med: (1) vann, (2) cariogenanase (250 enheter/ml), (3) dextranase (250 enheter/ml), (4) cariogenanase + dextranase (250 + 250 enheter/ml) og (5) cariogenanase + dextranase (250 + 250 enheter/ml) kokt . In vitro coatings on the bottom and walls of 5 small tared culture flasks were formed by cultivation of Streptococcus mutans. These coatings were treated separately with: (1) water, (2) cariogenanase (250 units/ml), (3) dextranase (250 units/ml), (4) cariogenanase + dextranase (250 + 250 units/ml) and (5) cariogenanase + dextranase (250 + 250 units/ml) boiled .

Efter 3 timers inkubering under forsiktig svingende rysting, ble den overstående inkuberingsvæske fradekantert. Følgende resultater ble erholdt: After 3 hours of incubation under gentle oscillating shaking, the supernatant incubation liquid was decanted. The following results were obtained:

Det vil sees at (4), blandingen av enzymer, har en større virkning enn hver enkelt av de to enzymer eller summen av deres separate virkninger. Den kokte enzymblanding hvor enzymene var denaturert, er sammenlignbar i aktivitet med vannet. It will be seen that (4), the mixture of enzymes, has a greater effect than each of the two enzymes or the sum of their separate effects. The boiled enzyme mixture where the enzymes were denatured is comparable in activity to the water.

Eksempel 1 Example 1

Eksempel 2 Eksempel 3 Example 2 Example 3

Eksempel 4 Example 4

Claims (1)

Tannpleiemiddel for å hindre dannelse av tannbelegg, hvilket middel inneholder dextranase og eventuelt protease, karakterisert ved at det dessuten inneholder cariogenanase, som enzymatisk spalter i tannbelegg tilstedeværende cariogenan (dvs. rettkje'det glucan med a-(1—*3) -bindinger og a-(l—£2)-bindinger i forholdet ca. 3;1), i en mengde på 5 - 20.000 enheter pr. 1 g eller 1 ml middel, hvilken cariogenanases systematiske navn er ~9lucan~3~glucanohydrolase og som er et endo-enzym som innvirker på andre enn endebindingene av polysaccharidkjeden,Dental care agent to prevent the formation of dental plaque, which agent contains dextranase and possibly protease, characterized in that it also contains cariogenanase, which enzymatically cleaves cariogenan present in dental plaque (i.e. straight-chain glucan with α-(1—*3) bonds and a-(1—£2) bonds in the ratio of approximately 3:1), in an amount of 5 - 20,000 units per 1 g or 1 ml agent, which cariogenase's systematic name is ~9lucan~3~glucanohydrolase and which is an endo-enzyme that acts on other than the terminal bonds of the polysaccharide chain, slik at spaltningsproduktene er hovedsakelig di-, tri- og andre oligosaccharider, og som kjennetegnes ved a) spesifisitet til en slik a-(l—>3) -glucosidbinding, i hvis nærhet der finnes en a-(1—42)-glucosidbinding, b) et isoelektrisk punkt på 5,1, og "c) en optimalaktivitet, som dekker et vidt pH-omrade, med toppaktivitet ved 6,0.so that the cleavage products are mainly di-, tri- and other oligosaccharides, and which are characterized by a) specificity of such an α-(l—>3)-glucosidic bond, in the vicinity of which there is an α-(1—42)-glucosidic bond , b) an isoelectric point of 5.1, and "c) an optimum activity, covering a wide pH range, with peak activity at 6.0.
NO4721/72A 1971-08-10 1972-12-21 DENTAL CARE FOR AA PREVENT THE FORMATION OF DENTAL COATINGS NO139590C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17064271A 1971-08-10 1971-08-10

Publications (2)

Publication Number Publication Date
NO139590B true NO139590B (en) 1979-01-02
NO139590C NO139590C (en) 1979-04-11

Family

ID=22620719

Family Applications (2)

Application Number Title Priority Date Filing Date
NO2703/72A NO138411C (en) 1971-08-10 1972-07-28 PROCEDURE FOR THE PREPARATION OF AN ENZYME DESIGNATED AS CARIOGENANASE
NO4721/72A NO139590C (en) 1971-08-10 1972-12-21 DENTAL CARE FOR AA PREVENT THE FORMATION OF DENTAL COATINGS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO2703/72A NO138411C (en) 1971-08-10 1972-07-28 PROCEDURE FOR THE PREPARATION OF AN ENZYME DESIGNATED AS CARIOGENANASE

Country Status (28)

Country Link
JP (2) JPS4826973A (en)
AR (1) AR198389A1 (en)
AT (1) AT333967B (en)
AU (1) AU462230B2 (en)
BE (1) BE787379A (en)
BG (1) BG25658A3 (en)
CA (1) CA1001573A (en)
CH (2) CH584288A5 (en)
CS (1) CS191162B2 (en)
DD (1) DD97897A5 (en)
DE (2) DE2239252C3 (en)
EG (1) EG10810A (en)
ES (1) ES405471A1 (en)
FI (1) FI49677C (en)
FR (1) FR2150754B1 (en)
GB (1) GB1385095A (en)
HU (1) HU165227B (en)
IE (1) IE36619B1 (en)
IL (2) IL46743A (en)
LU (1) LU65867A1 (en)
NL (1) NL175733C (en)
NO (2) NO138411C (en)
PH (1) PH16242A (en)
PL (1) PL89658B1 (en)
RO (1) RO84249B (en)
SE (1) SE405936B (en)
SU (1) SU465796A3 (en)
ZA (1) ZA725462B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5146874A (en) * 1974-10-18 1976-04-21 Mitsubishi Electric Corp Handotaisochino seizohoho
JPS5750071B2 (en) * 1974-10-25 1982-10-25
FR2311406A1 (en) * 1975-05-13 1976-12-10 Honeywell Bull Soc Ind IMPROVEMENTS IN THE MANUFACTURING METHODS OF PACKAGING SUPPORTS FOR MICRO-PLATELETS OF INTEGRATED CIRCUITS
JPS5851831B2 (en) * 1976-08-18 1983-11-18 松下電器産業株式会社 Thermal head device
JPS5851830B2 (en) * 1976-05-31 1983-11-18 松下電器産業株式会社 thermal head
JPS5352366A (en) * 1976-10-23 1978-05-12 Seiko Epson Corp Packaging method of semiconductor device
JPS592627B2 (en) * 1976-10-26 1984-01-19 松下電器産業株式会社 thermal recording head
JPS5845901Y2 (en) * 1977-10-18 1983-10-19 株式会社東芝 thermal print head
EP0030393B1 (en) * 1979-10-26 1983-06-15 Shell Internationale Researchmaatschappij B.V. Xanthanase enzyme and its production
JPS57165312A (en) * 1981-04-03 1982-10-12 Handai Biseibutsubiyou Kenkyukai Production of oral composition
JPS5961545U (en) * 1982-10-19 1984-04-23 株式会社デンソー integrated circuit device
JPH0685690B2 (en) * 1988-09-26 1994-11-02 明治製菓株式会社 Method for producing hard candy containing enzyme

Also Published As

Publication number Publication date
PL89658B1 (en) 1976-12-31
DE2239252B2 (en) 1977-12-22
JPS54147938A (en) 1979-11-19
SU465796A3 (en) 1975-03-30
DE2265327C3 (en) 1980-03-13
AT333967B (en) 1976-12-27
BE787379A (en) 1973-02-09
NO138411C (en) 1978-08-30
CA1001573A (en) 1976-12-14
ZA725462B (en) 1974-07-31
IL46743A (en) 1975-12-31
BG25658A3 (en) 1978-11-10
DE2239252C3 (en) 1978-08-31
IL40036A0 (en) 1972-10-29
AU4527972A (en) 1974-02-07
IE36619L (en) 1973-02-10
DE2265327A1 (en) 1977-07-28
HU165227B (en) 1974-07-27
GB1385095A (en) 1975-02-26
FR2150754A1 (en) 1973-04-13
SE405936B (en) 1979-01-15
EG10810A (en) 1976-06-30
IE36619B1 (en) 1977-01-19
ES405471A1 (en) 1975-09-01
IL40036A (en) 1975-12-31
LU65867A1 (en) 1973-02-08
DE2265327B2 (en) 1979-05-10
FI49677B (en) 1975-06-02
DD97897A5 (en) 1973-05-20
NO139590C (en) 1979-04-11
AU462230B2 (en) 1975-06-19
CH587657A5 (en) 1977-05-13
RO84249B (en) 1984-07-30
NL175733B (en) 1984-07-16
FI49677C (en) 1975-09-10
NO138411B (en) 1978-05-22
NL175733C (en) 1984-12-17
FR2150754B1 (en) 1976-08-20
DE2239252A1 (en) 1973-03-01
CS191162B2 (en) 1979-06-29
PH16242A (en) 1983-08-11
CH584288A5 (en) 1977-01-31
NL7210466A (en) 1973-02-13
RO84249A (en) 1984-05-23
AR198389A1 (en) 1974-06-21
JPS4826973A (en) 1973-04-09

Similar Documents

Publication Publication Date Title
Kaminishi et al. Isolation and characteristics of collagenolytic enzyme produced by Candida albicans
US4353891A (en) Mutanase
Makinen Salivary enzymes
JP3440694B2 (en) Oral composition
KR950003444A (en) Maltose-trehalose converting enzyme and preparation method and use thereof
NO139590B (en) DENTAL CARE FOR AA PREVENT THE FORMATION OF DENTAL COATINGS
US6254856B1 (en) Compositions for the removal of dental plaque
Newbrun Extracellular Polysaccharides Synthesized by Glucosyltransferases of Oral Streptococci: Composition and Susceptibility to Hydrolysis
US4438093A (en) Oral composition containing dextranase and α-1,3 glucanase and a method for preventing and suppressing oral diseases using the same
JP2939491B2 (en) Functional food
US3985869A (en) Dental caries-inducing microorganism cells lytic enzyme
US3929579A (en) Dental caries-inducing microorganism cells lytic enzyme
Fukui et al. Neuraminidase activity in some bacteria from the human mouth
Da Costa et al. Dextran hydrolysis by a Fusobacterium strain isolated from human dental plaque
KIM et al. Characterization of a novel carbohydrase from Lipomyces starkeyi KSM 22 for dental application
Larner et al. ACTION OF INTESTINAL EXTRACTS ON “BRANCHED” OLIGOSACCHARIDES1
JPH0363215A (en) Bacterial plaque decomposition composition
JP3516104B2 (en) Mutanase producing microorganism and mutanase
JP3516105B2 (en) Mutanase producing microorganism and mutanase
US4159317A (en) Method for preventing alveolar pyorrhea
CN114681350B (en) Detergent composition containing lysozyme
Greenman et al. Hydrolysis of triclosan monophosphate by dental plaque and selected species of oral micro-organisms
JPS62210986A (en) Novel lipase
KOBAYASHI et al. Preparation and some properties of a novel maltotetraose-forming enzyme of Pseudomonas saccharophila
JPH0937773A (en) Mutanase producing bacterium and mutanase